On this page
  • Find out about Medibank’s board of directors
  • Meet our executive committee members

Board of Directors

  • Elizabeth Alexander AM

    BCom, FAICD, FCA, FCPA

    Chairman and Independent Non-executive Director

    • Elizabeth was appointed a director in October 2008 and Chairman in March 2013. She is Chairman of the Nomination Committee and member of the Audit and Risk Management Committee.
    • As a former partner at PricewaterhouseCoopers (1977–2002), Elizabeth specialised in the area of risk management and corporate governance.
    • Elizabeth is currently Chairman of DEXUS Wholesale Property Limited and a director of DEXUS Funds Management Limited as part of the DEXUS Property Group, and a director of the IOOF Foundation and the Victorian Registration and Qualifications Authority.
    • Elizabeth was previously Chairman of CSL Limited and a director of Boral Limited and Amcor Limited, and the former Chancellor of the University of Melbourne and Chair of its Finance Committee. She is a former Chair of the Australian Prudential Regulation Authority’s Risk and Audit Committee. Elizabeth is also a former National President of CPA Australia and the Australian Institute of Company Directors, and a former member of the Takeovers Panel.

  • Craig Drummond

    BCom, CA, SF Fin

    Managing Director and Chief Executive Officer

    • Craig was appointed Managing Director and Chief Executive Officer on 4 July 2016. He is a member of the Investment and Capital Committee.
    • Craig is a Director of the Geelong Football Club Limited and the Florey Institute of Neuroscience and Mental Health. He is also a member of the Finance Committee of the Ian Potter Foundation Limited.
    • Prior to joining Medibank, Craig was Group Executive Finance and Strategy of National Australia Bank Limited (NAB), having joined NAB in November 2013. At NAB, his focus was the strategic realignment and repositioning of the bank, its balance sheet and its performance management systems.
    • Prior to NAB, Craig was Chief Executive Officer and Country Head of Bank of America. Earlier in his career, Craig joined JBWere, a leading Australian stockbroker and wealth manager, in equity research and subsequently held roles including Chief Operating Officer, Chief Executive Officer and Executive Chairman of Goldman Sachs JBWere.

Non-executive directors

  • Anna Bligh AC

    BA (QLD)

    Independent Non-executive Director

    • Anna was appointed a director in December 2012. She is a member of the Investment and Capital Committee and the People and Remuneration Committee.
    • Anna has extensive experience in leadership and public policy, including in the fields of healthcare, finance, infrastructure and project management. Anna is currently the Chief Executive Officer of the Australian Bankers’ Association and a director of Bangarra Dance Theatre Australia. Anna previously held several roles in the Queensland Government, including Premier, Treasurer, Minister for Finance, Minister for State Development, Minister for Trade and Innovation and Minister for Education. She was also a member of the Queensland Cabinet Budget Review Committee for 11 years.

  • David Fagan

    LLB, LLM, GAICD

    Independent Non-executive Director

    • David was appointed a director in March 2014. He is a member of the Investment and Capital Committee and the People and Remuneration Committee
    • David is a highly experienced banking and major projects lawyer with more than 35 years experience. He acted for major banks and corporate clients with Clayton Utz, and was Clayton Utz’s Chief Executive Partner from May 2001 to June 2010. David is a director and Chair of the Audit Committee of The Global Foundation, and a director of Hilco Merchant Australia Pty Limited, Hilco Oz Pty Limited and Grocon Funds Management Group. He is a director and Chair of the Audit and Risk Committee of UBS Grocon Real Estate Investment Management and on the advisory board of Chase Corporate Advisory. David also chaired the Medibank Privatisation Committee which operated during 2014 in preparation for the privatisation process.

  • Dr Cherrell Hirst AO

    FTSE, MBBS, BEdSt D. Univ (Hon), FAICD

    Independent Non-executive Director

    • Cherrell was appointed a director in December 2009. She is a member of the Audit and Risk Management Committee and the People and Remuneration Committee.
    • Cherrell has practised medicine for 30 years and is a highly experienced company director.
    • Cherrell is the Chairman of ImpediMed Limited and Factor Therapeutics Limited. She is a director of Gold Coast Hospital and Health Service, and RSL Care Limited. She is also Chairman of the Advisory Board of the Institute of Molecular Bioscience at the University of Queensland. Cherrell is a former director of Telesso Technologies Limited, Suncorp Group Limited, Avant Mutual Group and Avant Insurance Limited. From 1994 to 2004, Cherrell was Chancellor of the Queensland University of Technology.

  • Peter Hodgett

    BSc (Hons), FIAA, FAHRI, FAICD

    Independent Non-executive Director

    • Peter was appointed a director in June 2013. He is Chairman of the Investment and Capital Committee, and a member of the Audit and Risk Management Committee and the Nomination Committee.
    • Peter is currently a director of Colonial First State Investments Limited, Colonial Mutual Superannuation Pty Limited and Avanteos Investments Limited. Previously, Peter worked for AMP for more than 20 years in a wide variety of business and functional roles, including Chief Actuary during its demutualisation, General Manager of Human Resources and Strategy, and as Global Director of Finance and Operations for Henderson Global Investors in the United Kingdom.

  • Linda Bardo Nicholls AO

    BA, MBA (Harvard), FAICD

    Independent Non-executive Director

    • Linda was appointed a director in March 2014. She is Chairman of the People and Remuneration Committee and a member of the Nomination Committee.
    • Linda has more than 30 years experience as a senior executive and director in banking, insurance and funds management in Australia, New Zealand and the United States. She is Chairman of Japara Healthcare Limited and a director of Inghams Enterprises Pty Limited, Fairfax Media Limited and the Olivia Newton-John Cancer Research Institute. Linda was previously Chairman of KDR Victoria Pty Ltd (Yarra Trams), Healthscope Limited and Australia Post, and a director of Pacific Brands Limited, St George Bank, Sigma Pharmaceuticals Limited and Insurance Manufacturers of Australia. Linda was also a member of the Walter and Eliza Hall Institute of Medical Research.

  • Christine O'Reilly

    BBus

    Independent Non-executive Director

    • Christine was appointed a director in March 2014. She is Chairman of Audit and Risk Management Committee and a member of the Nomination Committee.
    • Christine has more than 30 years of financial and infrastructure experience both in Australia and internationally. Christine is currently a director of CSL Limited, Transurban Group, EnergyAustralia and Baker IDI, and is Deputy Chair of Care Australia. She was formerly Co-head of Unlisted Infrastructure at Colonial First State Global Asset Management, and prior to that was Chief Executive and Managing Director of GasNet Australia Group.

  • Mike Wilkins

    BCom, MBA

    Independent Non-executive Director

    • Mike was appointed a director in May 2017.
    • Mike has more than 30 years of experience in financial services, predominantly in Australia and Asia. He served as Managing Director and Chief Executive Officer at Insurance Australia Group, Managing Director and Chief Executive Officer at Promina Group Limited and Managing Director at Tyndall Australia Limited.
    • Mike is currently a director of AMP Limited and QBE Insurance Group Limited. He was previously a director of Maple-Brown Abbott Limited, Alinta Limited, The Geneva Association and the Australian Business and Community Network.



Executive leadership team

  • Kylie Bishop

    Group Executive - People & Culture

    • Kylie was appointed Group Executive - People & Culture in July 2013.
    • She is responsible for leading the key people functions across Medibank including learning and development, talent, capability and culture, performance and reward, shared services, workplace relations and health, safety and wellbeing.
    • Kylie formerly held the position of General Manager, Culture, Capability and Communications. Most recently, Kylie was responsible for overseeing the consolidation of six premises in Melbourne into one purpose-built headquarters designed for Better Health. Kylie continues to lead the business in its activity-based work transformation program.
    • Prior to joining Medibank in 2010, Kylie held senior positions with National Australia Bank (NAB) and also led a number of human resources consulting teams. A registered psychologist, Kylie began her career in HR consulting, specialising in organisational psychology.

  • John Goodall

    Group Executive - Technology & Operations

    • John was appointed Group Executive - Technology & Operations in December 2016.
    • He is responsible for Medibank’s core IT platforms, finalising the implementation of Project DelPHI and delivering enhanced service outcomes for Medibank’s customers.
    • John has over 25 years experience working in and leading IT functions across the retail and financial services industries and utilising technology to drive business growth and align business systems and processes to customer needs.
    • Before joining Medibank, John held the role of GM Enterprise Technology at Sportsbet.
    • Prior to this, he spent 20 years at GE Capital Australia and New Zealand where he held a number of roles including Chief Information Officer.

  • David Koczkar

    Group Executive - Chief Customer Officer

    • David was appointed Group Executive - Chief Customer Officer in September 2016. He previously held the role of Chief Operating Officer (from March 2014) and was Acting Chief Executive Officer between April 2016 and June 2016.
    • He is responsible for Medibank Group’s customer strategy and experience, comprising the areas of brand and marketing, product and portfolio management, sales and service, and digital transformation.
    • Prior to joining Medibank, David was the Group Chief Commercial Officer at Jetstar where he was responsible for all revenue generation, business development and commercial operations for the Jetstar group of airlines, including as a Director of Jetstar Pacific (Vietnam), Jetstar Hong Kong and NewStar (Singapore) JV businesses.
    • David has a wealth of commercial and business experience, including previous work in strategy consulting and financial services, and was part of the core team that developed the business case for Jetstar and built it into a successful Pan-Asian business.

  • Mei Ramsay

    Group Executive - Legal, Governance & Regulatory Affairs

    • Mei was appointed Group Executive - Legal, Governance & Regulatory Affairs in September 2016, previously having held the position of Group General Counsel from 2011. She was appointed Company Secretary in 2014.
    • She is responsible for providing legal and regulatory compliance advice to Medibank's Board, CEO and senior management. As Company Secretary, she is also responsible for continuous disclosure compliance and corporate governance.
    • Mei was the lead lawyer responsible for Medibank’s initial public offering on the Australian Securities Exchange (ASX).
    • She has over 20 years of experience in the legal profession, working in both private practice and in-house.
    • Prior to joining Medibank, Mei was the General Counsel and Company Secretary for the Asia Pacific Distribution Operations of Cummins Inc, and held senior legal positions at Coles Myer and Southcorp.
    • Mei is a director on the Australian Board of the Association of Corporate Counsel and the Immediate Past President of the Victorian Division.

  • Mark Rogers

    Group Executive - Chief Financial Officer

    • Mark was appointed Group Executive - Chief Financial Officer in January 2017.
    • He is responsible for the finance, actuarial, treasury and investor relations functions across Medibank.
    • Mark has more than 20 years experience spanning health and financial services.
    • Before joining Medibank, Mark held the role of General Manager, Group Performance and Planning at National Australia Bank (NAB) since 2013, where he was responsible for management reporting, performance management, planning and forecasting, and capital allocation. Preceding this, Mark was General Manager, Group Development.
    • Prior to this, Mark was responsible for Group Strategy and Development for the Mayne Group, where he was accountable for the management of the Group’s strategy, capital management and was involved in health sector related customer and supplier negotiations. While at the Mayne Group, Mark also led Group Investor Relations.

  • Dr Andrew Wilson

    Group Executive - Healthcare & Strategy

    • Andrew was appointed Group Executive - Healthcare & Strategy in September 2016, having previously held the role of Executive General Manager - Provider Networks & Integrated Care since 2013.
    • He is responsible for Medibank’s Group strategy and the Medibank Health Solutions business, which provides health services on behalf of business and government including the management of healthcare delivery for the Australian Defence Force. He is also responsible for Medibank’s healthcare purchasing, relationships with providers and enhanced care initiatives to support members in primary and community settings.
    • Andrew has 25 years experience in the health system, and remains a practising clinician and lecturer.
    • He was a founder and Co-president of McKesson Asia-Pacific, which was acquired by Medibank in 2010.
Back to top